Invention Grant
- Patent Title: Benzodiazepine derivatives as CCK2/gastrin receptor antagonists
-
Application No.: US15502490Application Date: 2015-08-07
-
Publication No.: US10308627B2Publication Date: 2019-06-04
- Inventor: Malcolm James Boyce , Liv Thomsen , Donald Alan Gilbert , David Wood
- Applicant: Trio Medicines Ltd
- Applicant Address: GB Brighton East Sussex
- Assignee: TRIO MEDICINES LTD
- Current Assignee: TRIO MEDICINES LTD
- Current Assignee Address: GB Brighton East Sussex
- Agency: Lathrop Gage LLP
- Agent Brian C. Trinque; Benjamin A. Vaughan
- Priority: GB1414116.2 20140808
- International Application: PCT/GB2015/052291 WO 20150807
- International Announcement: WO2016/020698 WO 20160211
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D223/16 ; A61P1/14 ; C07D401/04
Abstract:
The invention relates to benzodiazepine derivatives of formula (A) useful as CCK2/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK2/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.
Public/Granted literature
- US20180215728A1 Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists Public/Granted day:2018-08-02
Information query
